We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rapid DNA Sequencing Technology Could Improve Treatment for Fracture-Related Infections

By HospiMedica International staff writers
Posted on 12 Jun 2025

Fracture-related infections are a serious complication after broken bone surgeries, potentially arising at any point during treatment. More...

These infections can significantly prolong recovery, impair bone healing, cause permanent disability or even amputation, and often require repeated surgeries, costing the healthcare system billions annually. Despite progress in orthopedic trauma care, treatment for these infections still fails in about 30% of cases. Now, a new multicenter clinical trial is evaluating whether rapid next-generation DNA sequencing can improve patient outcomes and reduce the rate of treatment failure and recurrent infection.

The study, led by researchers at Indiana University School of Medicine (Indianapolis, IN, USA), is being conducted through the Major Extremity Trauma Research Consortium, which comprises over 80 trauma centers across the U.S. and Canada. The research spans 15 clinical sites and will follow 250 patients, aged 18 to 84, over the course of four years. It brings together a multidisciplinary team of experts in trauma, infectious diseases, and molecular diagnostics. Unlike traditional diagnostic methods such as polymerase chain reaction (PCR) and culture tests — which are limited in their ability to detect a broad range of pathogens — next-generation sequencing reads microbial DNA to comprehensively identify bacteria and fungi present in a sample. This technology offers a more detailed and faster analysis of the infectious agents responsible for complications following orthopedic surgery.

Patients enrolled in the trial will receive standard care alongside next-generation sequencing diagnostics provided by industry partner MicroGenDX (Orlando, FL, USA). Hospital-based infectious disease specialists will use these sequencing results to tailor antibiotic treatment plans for each patient. Treatment effectiveness will then be monitored for one year, aligning with standard care protocols. If successful, this study could transform the management of fracture-related infections by enabling earlier, more precise interventions. Improved diagnostics may lead to fewer re-hospitalizations, less need for repeat surgeries or amputations, more survivors, and major cost savings for healthcare systems. Researchers believe next-generation sequencing may give clinicians more information to help them decide what the best course of action is for individual patients.

"We hope to get more information from the next-generation sequencing diagnostics that will uncover pathogens that would have not been identified by our current standard tools," said Roman M. Natoli, MD, PhD, associate professor of orthopedic surgery in the Department of Orthopedic Surgery at IU School of Medicine and principal investigator of the clinical trial. "This trial will allow us to choose more appropriate antibiotic treatment via next-generation sequencing results and ultimately, if we're correct, reduce the rate of failure for treating patients that have infections after fractures. We hope to not only reduce the failure rate in fracture-related infections but also bring wounded warriors and civilians to more optimal function, where they can return to active duty, work and life."

Related Links:
Indiana University School of Medicine
MicroGenDX


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.